Iviglob-EX


Combined with:

Nplate

Indications and Reactions:

Role Indications Reactions
Secondary
Idiopathic Thrombocytopenic Purpura 100.0%
No Therapeutic Response 66.7%
Drug Ineffective 33.3%
Concomitant
Idiopathic Thrombocytopenic Purpura 82.7%
Thrombocytopenia 4.9%
Product Used For Unknown Indication 1.5%
Myelodysplastic Syndrome 1.3%
Hyperparathyroidism Secondary 1.0%
Hypertension 1.0%
Immune Thrombocytopenic Purpura 1.0%
Anaemia 0.8%
Nausea 0.8%
Therapeutic Response Decreased 0.8%
Immunosuppression 0.6%
Pain 0.6%
Supplementation Therapy 0.6%
Anxiety 0.4%
Constipation 0.4%
Deep Vein Thrombosis 0.4%
Evans Syndrome 0.4%
Hiv Infection 0.4%
Hyperphosphataemia 0.4%
Keratosis Pilaris 0.4%
Therapeutic Response Decreased 19.5%
Platelet Count Decreased 18.0%
Drug Ineffective 14.1%
Death 6.3%
Thrombocytopenia 5.5%
Bone Marrow Reticulin Fibrosis 3.9%
Myelodysplastic Syndrome 3.1%
Non-hodgkin's Lymphoma 3.1%
Biopsy Bone Marrow Abnormal 2.3%
Cardiac Failure Congestive 2.3%
Cardiomyopathy 2.3%
Condition Aggravated 2.3%
Deep Vein Thrombosis 2.3%
Haemorrhage Intracranial 2.3%
Hospitalisation 2.3%
Hypogammaglobulinaemia 2.3%
Lymphadenopathy 2.3%
Platelet Count Abnormal 2.3%
Anaemia 1.6%
Brain Injury 1.6%

Drug Data